ANIK
Anika Therapeutics Inc
Price:  
17.87 
USD
Volume:  
71,106.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika WACC - Weighted Average Cost of Capital

The WACC of Anika Therapeutics Inc (ANIK) is 6.1%.

The Cost of Equity of Anika Therapeutics Inc (ANIK) is 8.20%.
The Cost of Debt of Anika Therapeutics Inc (ANIK) is 5.00%.

Range Selected
Cost of equity 5.70% - 10.70% 8.20%
Tax rate 18.90% - 22.40% 20.65%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 7.3% 6.1%
WACC

Anika WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.4 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.70% 10.70%
Tax rate 18.90% 22.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 7.3%
Selected WACC 6.1%